BRAF and melanoma: The pro-fibrotic stroma recently characterized in BRAF-mutant melanoma treated with TT is the hallmark of other solid malignancies, and in addition to promote tumor initiation, metastatic dissemination and drug resistance, it has been described to be responsible for immune evasion [50, 73].